Nanotechnology for fabrication of nanoparticles and nanoemulsion

Therapeutic agents, namely drugs (i.e. Active pharmaceutical ingredient, API), biopharmaceutical (e.g. protein/peptide/macromolecules) and natural products (e.g. Nigella sativa oil, alpha mangostin) may have drawback of either highly water-soluble or highly lipophilic. These two extreme properties c...

Full description

Bibliographic Details
Main Authors: Mohamed, Farahidah, Mohd Nor, Nurul Hafizah, Budipatama, Anugerah, Mohd Shafri, Mohd Affendi
Format: Proceeding Paper
Language:English
English
Published: 2017
Subjects:
Online Access:http://irep.iium.edu.my/72101/
http://irep.iium.edu.my/72101/2/Program%20Book%20Seminar%20%26%20Workshop%20Nanoteknologi%202017%281%29.pdf
http://irep.iium.edu.my/72101/8/72101_NANOTECHNOLOGY%20FOR%20FABRICATION.pdf
_version_ 1848787562904158208
author Mohamed, Farahidah
Mohd Nor, Nurul Hafizah
Budipatama, Anugerah
Mohd Shafri, Mohd Affendi
author_facet Mohamed, Farahidah
Mohd Nor, Nurul Hafizah
Budipatama, Anugerah
Mohd Shafri, Mohd Affendi
author_sort Mohamed, Farahidah
building IIUM Repository
collection Online Access
description Therapeutic agents, namely drugs (i.e. Active pharmaceutical ingredient, API), biopharmaceutical (e.g. protein/peptide/macromolecules) and natural products (e.g. Nigella sativa oil, alpha mangostin) may have drawback of either highly water-soluble or highly lipophilic. These two extreme properties can mask the actual efficacy of the agents regardless of route of administration due to poor absorption across biological membrane. Nanotechnology appear to provide potential solution to these problems. Here, we had attempted a fabrication of nanoparticles and nanoemulsion for DNA-Nigella sativa oil and Doxycycline-Nigella sativa, respectively. For the nanoparticles, DNA-Nigella sativa was encapsulated into biodegradable poly(lactide-coglycolide) (PLGA: glycolic acid to lactic acid ratio of 50:50; IV 0.1 dl/g) polymer with or without chitosan and with or without sorbitan surfactant, using emulsion-solvent evaporation technique. The chitosan molecular weight (MW) was also varied. The DNA-Nigella sativa (DNN) nanoparticles were characterized for particle size using dynamic light scattering, Nanosizer and zeta potential using a Zetasizer. The results revealed particles of size ~870 to 134 nm showing large variation when immersed in deionized water as compared to alkaline media. Zeta-potential showed negative values for non-chitosan particles and positive values for all chitosan-containing particles. Microimages from Field emission Scanning Electron Microscopy (FESEM) revealed DNN nanoparticles of less than 300 nm. For the nanoemulsion, 3 phases were separately prepared, namely doxycycline/preservatives as the aqueous phase, nigella sativa oil/eugenol as the oil phase and lecithin/surfactant as the nanoemulsifier phase. The three phases were added and homogenized at 3000 rpm using a vacuum homogeneous mixer. This method yielded about 300 nm nanoemulsion droplets, PDI of 0.4 and zeta potential of -69. Further rheological characterization revealed that the nanoemulsion had thixotropic property suitable for its intended use as local antibiotic injected into periodontal gum pocket. In conclusion, with appropriate fabrication method, nanotechnology can be potentially explored to mitigate inherent problems of highly lipophilic or hydrophilic therapeutic agents hence unmask actual efficacy of these agents.
first_indexed 2025-11-14T17:26:55Z
format Proceeding Paper
id iium-72101
institution International Islamic University Malaysia
institution_category Local University
language English
English
last_indexed 2025-11-14T17:26:55Z
publishDate 2017
recordtype eprints
repository_type Digital Repository
spelling iium-721012019-05-21T07:53:39Z http://irep.iium.edu.my/72101/ Nanotechnology for fabrication of nanoparticles and nanoemulsion Mohamed, Farahidah Mohd Nor, Nurul Hafizah Budipatama, Anugerah Mohd Shafri, Mohd Affendi RS Pharmacy and materia medica Therapeutic agents, namely drugs (i.e. Active pharmaceutical ingredient, API), biopharmaceutical (e.g. protein/peptide/macromolecules) and natural products (e.g. Nigella sativa oil, alpha mangostin) may have drawback of either highly water-soluble or highly lipophilic. These two extreme properties can mask the actual efficacy of the agents regardless of route of administration due to poor absorption across biological membrane. Nanotechnology appear to provide potential solution to these problems. Here, we had attempted a fabrication of nanoparticles and nanoemulsion for DNA-Nigella sativa oil and Doxycycline-Nigella sativa, respectively. For the nanoparticles, DNA-Nigella sativa was encapsulated into biodegradable poly(lactide-coglycolide) (PLGA: glycolic acid to lactic acid ratio of 50:50; IV 0.1 dl/g) polymer with or without chitosan and with or without sorbitan surfactant, using emulsion-solvent evaporation technique. The chitosan molecular weight (MW) was also varied. The DNA-Nigella sativa (DNN) nanoparticles were characterized for particle size using dynamic light scattering, Nanosizer and zeta potential using a Zetasizer. The results revealed particles of size ~870 to 134 nm showing large variation when immersed in deionized water as compared to alkaline media. Zeta-potential showed negative values for non-chitosan particles and positive values for all chitosan-containing particles. Microimages from Field emission Scanning Electron Microscopy (FESEM) revealed DNN nanoparticles of less than 300 nm. For the nanoemulsion, 3 phases were separately prepared, namely doxycycline/preservatives as the aqueous phase, nigella sativa oil/eugenol as the oil phase and lecithin/surfactant as the nanoemulsifier phase. The three phases were added and homogenized at 3000 rpm using a vacuum homogeneous mixer. This method yielded about 300 nm nanoemulsion droplets, PDI of 0.4 and zeta potential of -69. Further rheological characterization revealed that the nanoemulsion had thixotropic property suitable for its intended use as local antibiotic injected into periodontal gum pocket. In conclusion, with appropriate fabrication method, nanotechnology can be potentially explored to mitigate inherent problems of highly lipophilic or hydrophilic therapeutic agents hence unmask actual efficacy of these agents. 2017-10-30 Proceeding Paper NonPeerReviewed application/pdf en http://irep.iium.edu.my/72101/2/Program%20Book%20Seminar%20%26%20Workshop%20Nanoteknologi%202017%281%29.pdf application/pdf en http://irep.iium.edu.my/72101/8/72101_NANOTECHNOLOGY%20FOR%20FABRICATION.pdf Mohamed, Farahidah and Mohd Nor, Nurul Hafizah and Budipatama, Anugerah and Mohd Shafri, Mohd Affendi (2017) Nanotechnology for fabrication of nanoparticles and nanoemulsion. In: Seminar & Workshop Nanoteknologi 2017, 30th Oct. - 1st Nov. 2017, Yogyakarta, Indonesia. (Unpublished)
spellingShingle RS Pharmacy and materia medica
Mohamed, Farahidah
Mohd Nor, Nurul Hafizah
Budipatama, Anugerah
Mohd Shafri, Mohd Affendi
Nanotechnology for fabrication of nanoparticles and nanoemulsion
title Nanotechnology for fabrication of nanoparticles and nanoemulsion
title_full Nanotechnology for fabrication of nanoparticles and nanoemulsion
title_fullStr Nanotechnology for fabrication of nanoparticles and nanoemulsion
title_full_unstemmed Nanotechnology for fabrication of nanoparticles and nanoemulsion
title_short Nanotechnology for fabrication of nanoparticles and nanoemulsion
title_sort nanotechnology for fabrication of nanoparticles and nanoemulsion
topic RS Pharmacy and materia medica
url http://irep.iium.edu.my/72101/
http://irep.iium.edu.my/72101/2/Program%20Book%20Seminar%20%26%20Workshop%20Nanoteknologi%202017%281%29.pdf
http://irep.iium.edu.my/72101/8/72101_NANOTECHNOLOGY%20FOR%20FABRICATION.pdf